Arcus shares kidney cancer trial data for casdatifan drug
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro boost AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| (NYSE: RCUS) | Delayed: 19.45 -4.3 (18.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.75 | 52 Week High | $ | |||
| Open | $24.47 | 52 Week Low | $ | |||
| Day High | $24.47 | P/E | N/A | |||
| Day Low | $19.27 | EPS | $ | |||
| Volume | 2,816,105 | |||||
